Us Bcr-Abl Antibody Market Size By Applications, By Type, By End-User, By Deployment & By Technology 2032
Bcr-Abl Antibody Market was valued at USD 1.2 Billion in 2022 and is projected to reach USD 2.5 Billion by 2030, growing at a CAGR of 10.2% from 2024 to 2030.
The United States Bcr-Abl antibody market is experiencing significant growth, driven by advancements in leukemia diagnostics and therapeutics. Bcr-Abl antibodies are crucial in detecting the Philadelphia chromosome, a genetic abnormality present in various leukemias, notably chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). This fusion gene results from a translocation between chromosomes 9 and 22, producing the Bcr-Abl oncoprotein with constitutive tyrosine kinase activity, leading to uncontrolled cell proliferation.
In 2023, the Bcr-Abl tests market was valued at $23.5 million, with projections indicating a compound annual growth rate (CAGR) exceeding 5% from 2023 to 2033. This upward trajectory is attributed to the increasing incidence of CML and ALL, heightened awareness, and the adoption of advanced diagnostic techniques. The market is segmented into Bcr-Abl In Situ Hybridization Tests and Bcr-Abl Nucleic Acid Amplification Tests (NAATs), with NAATs holding the largest market share in 2023.
Several key players dominate the U.S. Bcr-Abl antibody market, offering a diverse range of products tailored for research and clinical applications. Notable companies include:
Thermo Fisher Scientific: Provides the BCR-ABL Antibody (MA1-153), a mouse monoclonal antibody validated for applications such as immunocytochemistry, immunohistochemistry, immunoprecipitation, and western blotting.
Abcam: Offers the Anti-Bcr-abl antibody [7C6], suitable for western blotting, immunocytochemistry, and immunofluorescence, and available in various quantities.
Novus Biologicals: Supplies the BCR/ABL Antibody (4C12) [FITC], designed for immunocytochemistry, immunofluorescence, immunohistochemistry, and radioimmunoassay applications.
The robust pipeline of Bcr-Abl inhibitors further complements the antibody market. The global Bcr-Abl inhibitor market is projected to surpass $8 billion by 2028, driven by the rising prevalence of CML and ongoing research into novel therapeutic agents. The U.S. plays a pivotal role in this expansion, with over 100 clinical trials evaluating new Bcr-Abl inhibitors as monotherapies or in combination therapies across various cancers.
In my professional experience, the integration of Bcr-Abl antibody testing has revolutionized the diagnostic landscape for leukemia. Early detection through precise antibody assays enables timely therapeutic interventions, significantly improving patient outcomes. Collaborating with leading suppliers has provided access to high-quality antibodies, ensuring the reliability and accuracy of diagnostic procedures.
In summary, the U.S. Bcr-Abl antibody market is poised for continued growth, propelled by technological advancements, a deepening understanding of leukemia pathogenesis, and a commitment to improving patient care through early and accurate diagnosis.
Get an In-Depth Research Analysis of the Global Bcr-Abl Antibody Market Size And Forecast [2025-2032]
Â
Abbexa
Biorbyt
Bio-Techne
Creative Biolabs
LifeSpan BioSciences
Inc
​​Abcam
RayBiotech
Inc.
Assay Genie
Sino Biological
Inc.
Cell Signaling Technology
Inc.
GeneTex
Arigo Biolaboratories Corp.
MyBiosource
Inc.
OriGene Technologies
Inc.
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Bcr-Abl Antibody Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Bcr-Abl Antibody Market
Monoclonal Antibodies
Polyclonal Antibodies
Recombinant Antibodies
Research and Development
Diagnostic Testing
Therapeutic Use
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Hospitals and Clinical Laboratories
ELISA
Western Blotting
Immunohistochemistry
Flow Cytometry
Mouse
Rabbit
Human
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Bcr-Abl Antibody Market Research Analysis
1. Introduction of the Global Bcr-Abl Antibody Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Bcr-Abl Antibody Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Bcr-Abl Antibody Market, By Type
6. Global Bcr-Abl Antibody Market, By Application
7. Global Bcr-Abl Antibody Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Bcr-Abl Antibody Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/